Functional evidence for a novel suramin-insensitive pyrimidine receptor in rat small pulmonary arteries

Circulation Research

Volumn 83, Issue 9, 1998, Pages 940-946

  Hartley, S Anthony ^a   Kato, Kenichi ^a   Salter, Katie J ^a   Kozlowski, Roland Z ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artery; Channel; Cl ; Nucleotide; Pulmonary; Uridine

Indexed keywords

CHLORIDE CHANNEL; PYRIMIDINE; RECEPTOR; SURAMIN; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ELECTROPHYSIOLOGY; LUNG VASOCONSTRICTION; MALE; MOLECULAR BIOLOGY; MYOGRAPHY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0032476559     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.9.940     Document Type: Article

References (32)

1. Yang S, Cheek DJ, Westfall DP, Buxton IL. Agonist-mediated release of ATP from cardiac endothelial cells. Circ Res. 1994;73:401-407.
2. Hashimoto M, Shinozuka K, Shahadat HM, Kwon YM, Tanabe Y, Kunitomo M, Masumura S. Antihypertensive effect of all-cis-8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery. J Vasc Res. 1998;35:55-62.
3. Bodin P, Burnstock G. ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol. 1996;27:872-875.
4. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2 purinoceptor? Gen Pharmacol. 1985;16:433-440.
5. Richards SM, Dora KA, Rattigan S, Colquhoun EQ, Clark MG. Role of extracellular UTP in the release of uracil from vasoconstricted hindlimb. Am J Physiol. 1993;264:H233-H237.
6. Urquilla PR, Van Dyke K, Trush M. Prolonged contraction of isolated human and canine cerebral arteries induced by uridine 5′-triphosphate. Stroke. 1978;9:133-136.
7. Dubyak GR, El-Moatassim C. Signal transduction via P2 purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol. 1993;265:C577-C606.
8. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobsen KA, Schwabe U, Williams M. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci. 1997;18:79-82.
9. Vials AJ, Burnstock G. Effects of pyrimidines on the guinea-pig coronary vasculature. Br J Pharmacol. 1993;110:1091-1097.
10. Von Kugclcn I, Hussinger D, Starke K. Evidence for a vasoconstriction-mediating receptor for UDP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol. 1987;336:556-560.
11. Saiag B, Milon D, Hallain H, Rault B, Van Den Driessche J. Constriction of the rat tail and femoral arteries and dog saphenous vein is induced by uridine triphosphate via "pyrimidinoceptors," and by adenosine triphosphate via P2X purinoceptors. Blood Vessels. 1990;27:352-364.
12. Rubino A, Burnstock G. Evidence for a P2 purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br J Pharmacol. 1996;118:1415-1420.
13. Lustig KD, Shiau AK, Brake AJ, Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A. 1993;90:5113-5117.
14. Lazarowski ER, Harden TK. Identification of a uridine-nucleotide-selective G protein-linked receptor that activates phospholipase C. J Biol Chem. 1994;269:11830-11836.
15. Chang K, Hanaoka K, Kumada M, Takuwa Y. Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J Biol Chem. 1995;270:26152-26158.
16. Communi D, Parmentier M, Boeynaems J-M. Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun. 1996;222:303-308.
17. Nicholas RA, Watt WC, Lazarowski ER, Li Q, Harden TK. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol. 1996;50:224-229.
18. Hartley SA, Kozlowski RZ. Electrophysiological consequences of purinergic receptor stimulation in isolated rat pulmonary arterial myocytes. Circ Res. 1997;80:170-178.
19. Qasabian RA, Schyvens C, Owe-Young R, Killen JP, MacDonald PS, Conigrave AD, Williamson DJ. Characterization of the P2 receptors in rabbit pulmonary artery. Br J Pharmacol. 1997;120:553-558.
20. Yang S, Buxton IL, Probert CB, Talbot JN, Bradley ME. Evidence for a discrete UTP receptor in cardiac endothelial cells. Br J Pharmacol. 1996;177:1572-1578.
21. Matsumoto T, Nakame T, Chiba S. UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptors. Br J Pharmacol. 1997;122:1625-1632.
22. Albarwani S, Heinert G, Turner JL, Kozlowski RZ. Differential K+ channel distribution in smooth muscle cells isolated from the pulmonary arterial tree of the rat. Biochem Biophys Res Commun. 1995;208: 183-189.
23. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92:145-159.
24. 2Y purinoceptors: expression in rat heart. J Autonom Pharmacol. 1996;16: 303-307.
25. + channels and their modulation by endothelin-1 in rat pulmonary arterial smooth muscle cells. Exp Physiol. 1995;80:815-824.
26. Boarder MR, Weisman GA, Turner JT, Wilkinson GF. G protein-coupled P2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol Sci. 1995;16:133-139.
27. Dunn PM, Blakeley AGH. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988;93:243-245.
28. Hogg RC, Wang Q, Large WA. Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein. J Physiol (Lond). 1994; 112:977-984.
29. 2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y - but not the P2x - purinoceptor. Br J Pharmacol. 1987;90: 383-391.
30. Harden TK, Lazarowski ER, Boucher RC. Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol Sci. 1997;18:43-46.
31. Suprenant A. Functional properties of native and cloned P2X receptors. In: Chadwick, DJ, Goode, JA, eds. P2 Purinoceptors: Localization, Function and Transduction Mechanisms. Chichester (Ciba Foundation Symposium), NY: Wiley; 1996:208-219.
32. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J. 1986;233:309-319.